Repository of Research and Investigative Information Isfahan University of Medical Sciences
Not a member yet
23244 research outputs found
Sort by
Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
No full textBackground: Psoriasis is a common dermatologic disorder, with fluctuating response to treatment. Considering the proven immunomodulatory effects of oral simvastatin in psoriasis, this study aimed to determine whether the topical form has also antipsoriatic effects. Vitamin D analogs known to be effective and are considered the first line of therapy in mild to moderate cases. In this study, the efficacy of topical calcipotriol 0.005 ointment (as a standard method of treatment for psoriasis), versus combination of calcipotriol plus topical simvastatin was compared in the treatment of psoriasis. Methods: 80 patients with symmetric psoriasis who had body surface involvement up to 20 were divided randomly into 2 groups. Group A were treated with calcipotriol 0.005 ointment twice daily and group B with calcipotriol 0.005 ointment twice daily and simvastatin 3 ointment twice daily, for 12 weeks. The results were evaluated by a blind dermatologist using psoriasis area severity index (PASI) score at baseline, 4th, 8th and 12th weeks of treatment. In a similar way, a subjective assessment performed by patients based on photo-evaluation at the end of the study. Findings: Despite a continuous reduction in PASI score in both groups, according to both physician (P = 0.603) and patient (P = 0.243) assessments, topical simvastatin was not statistically more effective than conventional treatment of psoriasis. Conclusion: This study indicates that topical simvastatin is not associated with significant impacts in the treatment of psoriasis as compared to oral form. This study indicates that psoriasis is a systemic disorder with variable skin manifestations. © 2015, Isfahan University of Medical Sciences(IUMS). All rights reserved
Incidence and mortality of breast cancer and their relationship to development in Asia
No full textPurpose: This study aimed to investigate the incidence and mortality of breast cancer, and its relationship with human development index (HDI) and its components in Asia in 2012. Materials and Methods: This study was an ecologic study in Asia for assessment of the correlation between age-specific incidence rate (ASIR) and age-specific mortality rate (ASMR) with HDI and its details that include: life expectancy at birth, mean years of schooling and gross national income (GNI) per capita. Data about SIR and SMR for every Asian country for the year 2012 were obtained from the global cancer project. We used a bivariate method for assessment of the correlation between SIR and SMR and HDI and its individual components. Statistical significance was assumed if P < 0.05. All reported P-values are two-sided. Statistical analyses were performed using SPSS (Version 15.0, SPSS Inc.). Results: In 2012, 639,824 cases of breast cancer were recorded in Asian countries. Countries with the highest standardized incidence rate (ASIR) (per 100,000) were Israel (80.5), Lebanon (78.7), Armenia (74.1) and the highest standard mortality rate (ASMR) was observed in Pakistan (25.2), Armenia (24.2), and Lebanon (24). There was a positive correlation between the ASIR of breast cancer and HDI (r = 0.556, p < 0.001), whereas there was a negative correlation between the ASMR of breast cancer and HDI (r = -0.051). Conclusions: Breast cancer incidence in countries with higher development is greater, while mortality is greatest in countries with less development. There was a positive and significant relationship between the ASIR of breast cancer and HDI and its components. Also there was a negative but non significant relationship between the ASMR of breast cancer and HDI
Identification and comparison of the yield and composition of essential oil constituents of four Eucalyptus species adapted to the climatic conditions of khorramabad
No full textIntroduction: Eucalyptus has more than 400 species, while only a few species of this genus have been imported in Iran. In this study we aimed to investigate chemical compounds of the essential oils of Eucalyptus species adapted in Lorestan climate. Methods: In this study, the fresh young leaves of four different Eucalyptus species including E. suggrandis, E. globulus subsp. bicostata, E. nitens and E. globulus subsp. maidenii were collected in spring (the middle of May) in khorramabad, Iran. The powder of air-dried leaves of different species of Eucalyptus was subjected to hydro-distillation using a Clevenger-type apparatus. The chemical compositions of different essential oils were detected using gas chromatography (GC) and gas chromatography coupled with mass spectrometry (GC/MS) and determination of their retention time (RT), retention index (RI) and Mass Spectra. The obtained data were analyzed using SPSS software. Results: The results of this study indicated that there was significant difference (P<0.01) among the yield and chemical compounds of the essential oils of studied species. The results showed that the yield of essential oil extracted from E. suggrandis, E. globulus bicostata, E. nitens and E. globulus maidenii were 1.12, 1.34, 2.57 and 5.38, respectively. Conclusion: The essential oil constituents of four Eucalyptus species plant were different in among of some compounds. E. globulus maidenii had most content of essential oil and 1.8-Cineole compound so it is necessary to identify quality and quantity characteristics of compounds available in this plant
Preparation of immunotoxin herceptin-botulinum and killing effects on two breast cancer cell lines
No full textBackground: Worldwide, breast cancer is the most common cancer diagnosed among women and a leading cause of cancer deaths. The age of onset in Iran has become reduced by a decade for unknown reasons. Herceptin, a humanized monoclonal antibody, is a target therapy for breast cancer cells with over expression of HER2-neu receptors, but it is an expensive drug with only 20 beneficial rate of survival. This study introduces a novel approach to enhance the efficacy of this drug through immunoconjugation of the antibody to botulinum toxin. Decreasing the cost and adverse effects of the antibody were secondary goals of this study. Materials and Methods: Botulinum toxin was conjugated with Herceptin using heterobifunctional cross linkers, succinimidyl acetylthiopropionate (SATP) and sulfo-succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) according to the supplier's guidelines and tested on two breast cancer cell lines: SK-BR-3 and BT-474. Toxin and Herceptin were also used separately as controls. The cytotoxicity assay was also performed using the new bioconjugate on cultured cells with Alamar blue and a fluorescence plate reader. Results: Herceptin-Toxin bioconjugation significantly improved Herceptin efficacy on both breast cancer cell lines when compared to the control group. Conclusions: Toxin-Herceptin bioconjugation can be a potential candidate with increased efficiency for treating breast cancer patients with over expression of the HER2 receptor